Selective Defunctioning Stoma in Low Anterior Resection for Rectal Cancer

NCT06214988 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2025-05-21

No results posted yet for this study

Summary

The goal of this observational trial with a nested randomized controlled trial is to investigate a selective approach of defunctioning stoma in low anterior resection in rectal cancer patients. The primary outcome is a hybrid so-called textbook outcome; stoma-free survival at two years without major LARS, reflecting a functionally appropriate outcome after low anterior resection for rectal cancer. Secondary outcomes include anastomotic leakage, postoperative mortality, reinterventions, stoma-related complications, quality of life measures, LARS, and permanent stoma rate up to two years after index surgery.

Conditions

Interventions

PROCEDURE

selective approach defunctioning stoma

With randomisation to this experimental arm (selective approach), no defunctioning stoma is constructed.

Sponsors & Collaborators

  • Umeå University

    collaborator OTHER
  • Lund University

    collaborator OTHER
  • Göteborg University

    collaborator OTHER
  • Ersta Hospital, Sweden

    collaborator OTHER
  • Copenhagen University Hospital at Herlev

    collaborator OTHER
  • Linkoeping University

    collaborator OTHER_GOV
  • Oslo University Hospital

    collaborator OTHER
  • Örebro University, Sweden

    collaborator OTHER
  • Skane University Hospital

    lead OTHER

Principal Investigators

  • Pamela Buchwald, MD PhD · Skåne University Hospital, Lund University

  • Martin Rutegård, MD PhD · Umeå University Hospital, Umeå University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2027-12-31
Completion
2030-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06214988 on ClinicalTrials.gov